BACKGROUND: Colorectal cancer (CRC) is highly prevalent and lethal globally, and its prognosis remains unsatisfactory. Drug resistance is regarded as the main cause of treatment failure leading to tumor recurrence and metastasis. The overexpression of fucosylated epitopes, which are usually modifications of glycoproteins, was reported to occur in various epithelial cancers. However, the effects of treatments that target these antigens in colorectal cancer remain unclear.

METHODS: This study investigated the expression of heavily fucosylated glycans (HFGs) in 30 clinical samples from patients with CRC and other normal human tissues. The complement-dependent cytotoxicity was explored in vitro through treatment with anti-HFG monoclonal antibody (mAb) alone or in combination with chemotherapeutic agents. In vivo inhibitory effects were also examined using a xenograft mouse model.

RESULTS: Immunohistochemistry staining and western blotting revealed that HFG expression was higher in human colorectal cancer tissues than in normal tissues. In DLD-1 and SW1116 cells, which overexpress fucosylated epitopes, anti-HFG mAb produced observable cytotoxic effects, especially when it was combined with chemotherapeutic agents. The xenograft model also demonstrated that anti-HFG mAb had potent and dose-dependent inhibitory effects on colorectal tumor growth.

CONCLUSIONS: As a novel cancer antigen, HFGs are a promising treatment target, and the implementation of anti-HFG mAb treatment for CRC warrants further investigation.

Original languageEnglish
Pages (from-to)505
JournalJournal of Translational Medicine
Issue number1
Publication statusPublished - Jul 26 2023


  • Humans
  • Animals
  • Mice
  • Neoplasm Recurrence, Local
  • Immunohistochemistry
  • Antigens
  • Disease Models, Animal
  • Epitopes
  • Polysaccharides/pharmacology
  • Colorectal Neoplasms/pathology
  • Cell Line, Tumor


Dive into the research topics of 'Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer'. Together they form a unique fingerprint.

Cite this